Elimination of cytokines from plasma by ultrafiltration using conventional polysulfone or DIAPES® membranes

Contributions to Nephrology

Volumn 138, Issue , 2003, Pages 37-42

  Schindler, Ralf ^a,b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ADSORPTION; ARTICLE; ARTIFICIAL MEMBRANE; BLOOD; HUMAN; INSTRUMENTATION; ISOLATION AND PURIFICATION; METHODOLOGY; RENAL REPLACEMENT THERAPY; ULTRAFILTRATION;

ADSORPTION; CYTOKINES; HUMANS; MEMBRANES, ARTIFICIAL; RENAL DIALYSIS; ULTRAFILTRATION;

EID: 1842848692     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (11)

1. Damas P, Canivet JL, de Groote D, Vrindts Y, Albert A, Franchimont P, Lamy M:Sepsis and serum cytokine concentrations. Crit Care Med 1997;25:405-412.
2. Fisher CJ Jr, Slotman GJ, Opal SM, Pribble JP, Bone RC, Emmanuel G, Ng D, Bloedow DC, Catalano MA:Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebo-controlled multicenter trial. The IL-1RA Sepsis Syndrome Study Group. Crit Care Med 1994;22:12-21.
3. Goldie AS, Fearon KC, Ross JA, Barclay GR, Jackson RE, Grant IS, Ramsay G, Blyth AS, Howie JC:Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. The Sepsis Intervention Group. JAMA 1995;274:172-177.
4. Bellomo R, Tipping P, Boyce N:Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993;21:522-526.
5. Bellomo R, Baldwin I, Cole L, Ronco C:Preliminary experience with high-volume hemofiltration in human septic shock. Kidney Int Suppl 1998;66:S182-S185.
6. Heering P, Morgera S, Schmitz FJ, Schmitz G, Willers R, Schultheiss HP, Strauer BE, Grabensee B:Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med 1997;23:288-296.
7. Sanchez Izquierdo JA, Perez Vela JL, Lozano Quintana MJ, Alted Lopez E, Ortuno de Solo B, Ambros Checa A:Cytokines clearance during venovenous hemofiltration in the trauma patient. Am J Kidney Dis 1997;30:483-488.
8. De Vriese AS, Colardyn FA, Philippe JJ, Vanholder RC, De Sutter JH, Lameire NH:Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999;10:846-853.
9. Poole S, Bird TA, Selkirk S, Gaines-Das RE, Choudry Y, Stephenson SL, Kenny AJ, Saklatvaa J:Fate of injected interleukin 1 in rats: Sequestration and degradation in the kidney. Cytokine 1990; 2:416-422.
10. Metcalf D, Nicola NA:Tissue localization and fate in mice of injected multipotential colonystimulating factor. Proc Natl Acad Sci USA 1988;85:3160-3164.
11. Andersen SR, Lambrecht LJ, Swan SK, Cutler DL, Radwanski E, Affrime MB, Garaud JJ:Disposition of recombinant human interleukin-10 in subjects with various degrees of renal function. J Clin Pharmacol 1999;39:1015-1020.